The RITAI Cohort. An Observational Study on Serious Adverse Events Occuring After Rituximab Off-label Use for Auto-immune Disorders [Etude observationnelle des evenements indesirables graves survenant chez les patients traites par rituximab pour maladie dysimmunitaire hors polyarthrite rhumatoide]

Trial Profile

The RITAI Cohort. An Observational Study on Serious Adverse Events Occuring After Rituximab Off-label Use for Auto-immune Disorders [Etude observationnelle des evenements indesirables graves survenant chez les patients traites par rituximab pour maladie dysimmunitaire hors polyarthrite rhumatoide]

Completed
Phase of Trial: Phase III

Latest Information Update: 22 Oct 2012

At a glance

  • Drugs Rituximab (Primary)
  • Indications Rheumatoid arthritis
  • Focus Adverse reactions
  • Acronyms Cohorte RITAI; RITAI
  • Most Recent Events

    • 23 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top